- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2018-003867-79. Displaying page 1 of 1.
|EudraCT Number: 2018-003867-79||Sponsor Protocol Number: IDTX-MA-3004||Start Date*: 2018-11-07|
|Sponsor Name:Astellas Pharma Global Development, Inc.|
|Full Title: Astagraf XL® to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation|
|Medical condition: Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: Outside EU/EEA|
|Trial results: (No results available)|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.